NCT02651428 - Study Assessing Safety & Effectiveness of a Catheter Lock Solution in Dialysis Patients to Prevent Bloodstream Infection | Biotech Hunter

Enrollment

806

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

October 31, 2018

Study Completion Date

October 31, 2018

Conditions

Kidney Failure, ChronicCatheter-Related Infections

Interventions

DRUG

Neutrolin

Neutrolin® will be instilled into central venous HD catheters at the discontinuation of all dialysis sessions and will be withdrawn prior to the initiation of the next dialysis session

DRUG

Heparin

Heparin will be instilled into central venous HD catheters at the discontinuation of all dialysis sessions and will be withdrawn prior to the initiation of the next dialysis session

Trial Locations (5)

10016

Lower Manhattan Dialysis Center, New York

33169

North Beach Dialysis Center Inc., Miami Gardens

77004

Diagnostic Clinic of Houston, Houston

91773

North America Research Institute, San Dimas

92503

Riverside Nephrology Physicians/Van Buren Dialysis center, Riverside